A DOUBLE‐BLIND STUDY OF THE VALUE OF TREATMENT WITH A SINGLE DOSE TINIDAZOLE OF PARTNERS TO FEMALES WITH TRICHOMONIASIS

IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Acta Obstetricia et Gynecologica Scandinavica Pub Date : 2024-09-12 DOI:10.1111/j.1600-0412.1981.tb00037.x
Jens Lyng, Jan Christensen
{"title":"A DOUBLE‐BLIND STUDY OF THE VALUE OF TREATMENT WITH A SINGLE DOSE TINIDAZOLE OF PARTNERS TO FEMALES WITH TRICHOMONIASIS","authors":"Jens Lyng, Jan Christensen","doi":"10.1111/j.1600-0412.1981.tb00037.x","DOIUrl":null,"url":null,"abstract":"Tinidazole 2 g single oral dose was given to 137 females with positive trichomonal cultures. On a random basis the same dose of tinidazole was given to half the sexual partners, and matching placebo to the other half. One to two weeks after treatment 5 females had positive cultures, indicating a primary cure rate of 96.4%. At an average of 2 months after treatment and 6 weeks after resuming sexual activity, 118 females were reexamined; 17 had a positive culture, giving an overall relapse rate of 14.4%. The relapse rate with tinidazole‐treated partner was 5.1%, and with placebo‐treated partner 23.7% (p = 0.01). The definitive cure rate after a single dose of tinidazole 2 g was in females with treated partner 91.8% and with untreated partner 72.6%. It is concluded that a single dose of tinidazole is an effective treatment for females with trichomoniasis but to avoid relapse it is necessary to treat the sexual partner too, cond follow‐up, also with trichomonal culture. At this time they were questioned concerning their sexual activity: the date of first intercourse after treatment and the frequency of intercourse.","PeriodicalId":6990,"journal":{"name":"Acta Obstetricia et Gynecologica Scandinavica","volume":"38 1","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Obstetricia et Gynecologica Scandinavica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/j.1600-0412.1981.tb00037.x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Tinidazole 2 g single oral dose was given to 137 females with positive trichomonal cultures. On a random basis the same dose of tinidazole was given to half the sexual partners, and matching placebo to the other half. One to two weeks after treatment 5 females had positive cultures, indicating a primary cure rate of 96.4%. At an average of 2 months after treatment and 6 weeks after resuming sexual activity, 118 females were reexamined; 17 had a positive culture, giving an overall relapse rate of 14.4%. The relapse rate with tinidazole‐treated partner was 5.1%, and with placebo‐treated partner 23.7% (p = 0.01). The definitive cure rate after a single dose of tinidazole 2 g was in females with treated partner 91.8% and with untreated partner 72.6%. It is concluded that a single dose of tinidazole is an effective treatment for females with trichomoniasis but to avoid relapse it is necessary to treat the sexual partner too, cond follow‐up, also with trichomonal culture. At this time they were questioned concerning their sexual activity: the date of first intercourse after treatment and the frequency of intercourse.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
滴虫病女性患者伴侣单剂量替硝唑治疗价值的双盲研究
对 137 名滴虫培养呈阳性的女性口服 2 克替硝唑。随机给一半的性伴侣服用相同剂量的替硝唑,给另一半性伴侣服用相同剂量的安慰剂。治疗一至两周后,5 名女性的培养结果呈阳性,表明初步治愈率为 96.4%。在治疗后平均 2 个月和恢复性生活 6 周后,对 118 名女性进行了复查,其中 17 人的培养呈阳性,总复发率为 14.4%。接受替硝唑治疗的伴侣的复发率为 5.1%,接受安慰剂治疗的伴侣的复发率为 23.7%(P = 0.01)。单剂量 2 克替硝唑治疗后,女性患者的最终治愈率为 91.8%,未治疗的患者为 72.6%。结论是,单剂量替硝唑是治疗女性滴虫病的有效方法,但为了避免复发,有必要对性伴侣也进行治疗,并进行滴虫培养。在此期间,她们被询问了性活动情况:治疗后首次性交的日期和性交频率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
8.00
自引率
4.70%
发文量
180
审稿时长
3-6 weeks
期刊介绍: Published monthly, Acta Obstetricia et Gynecologica Scandinavica is an international journal dedicated to providing the very latest information on the results of both clinical, basic and translational research work related to all aspects of women’s health from around the globe. The journal regularly publishes commentaries, reviews, and original articles on a wide variety of topics including: gynecology, pregnancy, birth, female urology, gynecologic oncology, fertility and reproductive biology.
期刊最新文献
Maternal and perinatal outcomes of live births after uterus transplantation: A systematic review. Uterus transplantation: A bibliometric review of six-decade study from 1960 to 2024. Decreased expression of Syndecan- 1 (CD138) in the endometrium of adenomyosis patients suggests a potential pathogenetic role. Fetal rotation examined with ultrasound in a sub-Saharan population: A longitudinal cohort study. The complexity and challenges of fertility preservation in women with cervix cancer-A prospective cohort study reporting on reproductive outcome and overall survival.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1